The latest news from British Patient Capital
Press release 04 November 2024
British Patient Capital – Full Year Results for the period ending 31 March 2024
Driving long-term growth: British Patient Capital’s total fund and co-investment commitments reach £2.3 billion, retaining its position as the UK’s largest domestic investor in venture and venture growth capital. Total assets under management have now reached £3.125 billion.
Filter Close filters
Displaying 41 - 50 of 95 results
Filter news
Showing 41 - 50 of 95 results
-
British Patient Capital co-invests in cybersecurity platform CyberSmartPress release
23 February 2023 - British Patient Capital invests £5 million in quantum computing innovator Quantum Motion
Press release
21 February 2023 -
British Patient Capital invests $7m in immuno-oncology specialist Grey Wolf TherapeuticsPress release
26 January 2023 - British Patient Capital and Mubadala Invest in SV Biotech Crossover Opportunities Fund
Press release
16 January 2023 -
British Patient Capital invests £8.7m in Perspectum’s Series C funding roundPress release
05 January 2023 -
British Patient Capital invests £10m in semiconductor specialist PragmatICPress release
14 December 2022 - British Patient Capital Annual Report 2022
Press release
28 November 2022 - British Patient Capital invests £7.5 million in biotechnology leader Nucleome Therapeutics
Press release
19 October 2022 -
British Patient Capital commits €25 million to Finch Capital’s Fund IIIPress release
05 October 2022 -
Catherine Lewis La Torre appointed CEO, British Patient CapitalPress release
21 July 2022